Found "Vaccines": 74 results
Sort by
Z - A

Pneumococcal conjugate vaccines now introduced in Bhutan

In 2016 Bhutan graduated from Gavi support as its socioeconomic status change from lower-income to lower-middle income country, hence introducing new vaccines to its routine vaccination programme can pose a long-term financial burden to the government. However, since pneumococcal infections is a maj

PMAC 2016 Side Event (SE 012): Health Intervention and Technology Assessment (HITA): A Path to Universal Health Coverage (UHC)

PMAC 2016 Side Event (SE 012): Health Intervention and Technology Assessment (HITA): A Path to Universal Health Coverage (UHC)Given the global push to implement UHC, the importance of using evidence, namely health intervention and technology assessments (HITA), in governments’ decision making proces

Overcoming Barriers: Financing and Service Delivery for Vaccination in Fragile and Conflict-Affected States

Vaccination is a critical and cost-effective public health intervention that significantly reduces child mortality. Since the inception of the World Health Organization’s Expanded Program on Immunization (WHO-EPI) in 1974, vaccines have saved millions of lives, with a Lancet study highlighting that

Mission Report: Stakeholder Consultation Meeting on Pneumococcal Conjugate Vaccine (PCV) Project in Bhutan

Bhutan achieved Universal Child Immunization in 1991 and has maintained high immunization coverage over the past decades. Since Bhutan transitioned from Gavi support in 2016 after the country’s economic classification changed to lower‐middle income country, the government is now responsible for allo

Mission Report: Stakeholder Consultation Meeting on Pneumococcal Conjugate Vaccine (PCV) Project in Bhutan

Bhutan achieved Universal Child Immunization in 1991 and has maintained high immunization coverage over the past decades. Since Bhutan transitioned from Gavi support in 2016 after the country’s economic classification changed to lower‐middle income country, the government is now responsible for allo

Methodological Variation in Economic Evaluations Conducted in Low- and Middle- Income Countries: Information for Reference Case Development

Benjarin Santatiwongchai1, Varit Chantarastapornchit1*, Thomas Wilkinson2, Kittiphong Thiboonboon1, Waranya Rattanavipapong1, Damian G Walker3, Kalipso Chalkidou2, Yot Teerawattananon1 1 Health Intervention and Technology Assessment Program, Nonthaburi, Thailand, 2 NICE International,National Insti

Maternal Child and Health Voucher Scheme (MCHVS)

In 2008, Myanmar proposed the development of a Health System Strengthening (HSS) programme to the Global Alliance for Vaccines and Immunization (GAVI) and thus received funding and support for its initiative. The HSS framework aimed to shore up three main gaps which were identified: service delivery, programme coordination, and human resources. Ser

Join us in the Vaccinology Workshop on November 18-21 in India!

The Health Intervention and Technology Assessment Program (HITAP) would like to invite you to join and learn more about vaccines in a Policy Symposium and Workshop on Vaccinology for Clinical and Public Health Practice in Faridabad (near Delhi), India, on 18-21 November 2019. Join this event to

India to establish Medical Technology Assessment Board

Rhythma Kaul / Hindustand TimesNew Delhi: India announced the setting up of a Medical Technology Assessment Board (MTAB) that will be one-stop shop to review standards for medicines, vaccines, devices and insurance.The Board’s recommendations will be the last word for health policies and healthcare

IDSI Philippines

This project is part of the international Decision Support Initiative (iDSI), an innovative global partnership between leading government institutions, universities, and think tanks in the field of healthcare priority-setting. iDSI uniquely provides intellectual insight with hands-on field expertise, and delivers peer-to-peer support to policymaker
10 / Page